COVID-19 reinfection: the role of natural immunity, vaccines, and variants

COVID-19 reinfection: the role of natural immunity, vaccines, and variants

Blog Article

The COVID-19 pandemic has altered innumerable lives.Although here recent mass vaccinations offer a glimmer of hope, the rising death toll and new variants continue to dominate the current scenario.As we begin to understand more about SARS-CoV-2 infections, the territory of reinfections with COVID-19 remains unexplored.

In this review, we will discuss several aspects of reinfection: (a) How is COVID-19 reinfection characterized? (b) Does prior literature differentiate between reinfection and reactivation? (c) What SARS-CoV-2 depileve easy clean strains do the vaccines target and can they protect against new strains? Larger and longer timeline studies are needed to understand reinfection risks.With the ongoing distribution of the SARS-CoV-2 vaccines to provide protection, the understanding of the possibility for SARS-CoV-2 reinfection remains critical.Abbreviations CDC: Centers for Disease ControlSARS-CoV-2: Severe acute respiratory syndrome coronavirus 2COVID-19: Coronavirus disease 2019RT-PCR: Reverse Transcription Polymerase Chain ReactionPASC: Post-Acute Sequelae of SARS-CoV-2 infection.